Pinel S - Search Results

1

Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.

Pinel S, Barberi-Heyob M, Cohen-Jonathan E, Merlin JL, Delmas C, Plenat F, Chastagner P. Pinel S, et al. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):250-9. doi: 10.1016/j.ijrobp.2003.12.022. Int J Radiat Oncol Biol Phys. 2004. PMID: 15093922

2

Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts.

Pinel S, Chastagner P, Merlin JL, Marchal C, Taghian A, Barberi-Heyob M. Pinel S, et al. J Neurooncol. 2006 Jan;76(1):31-8. doi: 10.1007/s11060-005-3666-6. J Neurooncol. 2006. PMID: 16311843

3

A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.

Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, Viriot ML, Guillemin F, Barberi-Heyob M. Tirand L, et al. Among authors: pinel s. J Control Release. 2006 Mar 10;111(1-2):153-64. doi: 10.1016/j.jconrel.2005.11.017. Epub 2006 Jan 19. J Control Release. 2006. PMID: 16423422

4

Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?

Kremer S, Pinel S, Védrine PO, Bressenot A, Robert P, Bracard S, Plénat F. Kremer S, et al. Among authors: pinel s. J Neurooncol. 2007 Jun;83(2):111-9. doi: 10.1007/s11060-006-9260-8. Epub 2007 Apr 19. J Neurooncol. 2007. PMID: 17443290

5

Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts.

Scigliano S, Pinel S, Poussier S, Fouyssac F, Plenat F, Karcher G, Chastagner P. Scigliano S, et al. Among authors: pinel s. Int J Oncol. 2008 Jan;32(1):69-77. Int J Oncol. 2008. PMID: 18097544

6

Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts.

Labussière M, Aarnink A, Pinel S, Taillandier L, Escanyé JM, Barberi-Heyob M, Bernier-Chastagner V, Plénat F, Chastagner P. Labussière M, et al. Among authors: pinel s. Anticancer Drugs. 2008 Nov;19(10):991-8. doi: 10.1097/CAD.0b013e328313e172. Anticancer Drugs. 2008. PMID: 18827564

7

Proteasome inhibition by bortezomib does not translate into efficacy on two malignant glioma xenografts.

Labussiere M, Pinel S, Delfortrie S, Plenat F, Chastagner P. Labussiere M, et al. Among authors: pinel s. Oncol Rep. 2008 Nov;20(5):1283-7. Oncol Rep. 2008. PMID: 18949434

8

Phenomenological modeling of tumor diameter growth based on a mixed effects model.

Bastogne T, Samson A, Vallois P, Wantz-Mézières S, Pinel S, Bechet D, Barberi-Heyob M. Bastogne T, et al. Among authors: pinel s. J Theor Biol. 2010 Feb 7;262(3):544-52. doi: 10.1016/j.jtbi.2009.10.008. Epub 2009 Oct 14. J Theor Biol. 2010. PMID: 19835891 Free article.

9

Cellular response to cetuximab in PTEN-silenced head and neck squamous cell carcinoma cell line.

Mriouah J, Boura C, Pinel S, Chretien AS, Fifre A, Merlin JL, Faivre B. Mriouah J, et al. Among authors: pinel s. Int J Oncol. 2010 Dec;37(6):1555-63. doi: 10.3892/ijo_00000809. Int J Oncol. 2010. PMID: 21042725

10

Radiosensitizing properties of bortezomib depend on therapeutic schedule.

Labussière M, Pinel S, Vandamme M, Plénat F, Chastagner P. Labussière M, et al. Among authors: pinel s. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):892-900. doi: 10.1016/j.ijrobp.2010.09.051. Epub 2010 Dec 17. Int J Radiat Oncol Biol Phys. 2011. PMID: 21168283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters